Kane Biotech Inc. (KNBIF) Research

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.

Market snapshot

Symbol
KNBIF
Price
$0.03
Day change
0.00%
Market cap
$6.2M
P/E ratio
-2.46x
52-week range
0.0201-0.0451
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Bioxytran, Inc. (BIXT)
  • WEED, Inc. (BUDZ)
  • BioVaxys Technology Corp. (BVAXF)
  • Burzynski Research Institute, Inc. (BZYR)
  • Futura Medical plc (FAMDF)
  • Glow Lifetech Corp. (GLWLF)
  • MYND Life Sciences Inc. (MYNDF)
  • Qscreen Ai Inc. (PMEDF)

Open Kane Biotech Inc. (KNBIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.